ONDANSETRON
Zukastop

ZUKASTOP is indicated for the management of nausea and vomiting in adults induced by cytotoxic chemotherapy and radiotherapy, and for the prevention and treatment of postoperative nausea and vomiting (PONV). In the pediatric population, it is indicated for the management of chemotherapy-induced nausea and vomiting (CINV) in children aged over 6 months, and for the prevention and treatment of PONV in children aged over 1 month.

Packaging: Box of 5’s
Shelf Life: 36 months
Origin: India
Dosage Form: Solution for Injection